The page is the record's research on the issuer — no analyst, no rating, no view. # RECURSION PHARMACEUTICALS, INC. (NASDAQ: RXRX) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing The issuer is RECURSION PHARMACEUTICALS, INC., listed on NASDAQ under ticker RXRX, with ISIN US75629V1044. The LEI is not on the record (no GLEIF record with the exact legal name in jurisdiction US-DE). The security type is Corporate, the sector is 2836 Biological Products, (No Diagnostic Substances), and the jurisdiction is United States — Delaware. The segment is not on the record. The issuer is listed and not halted. ## The disclosure read The record holds 169 filings in the twelve months to 2026-11-08, across 100 filing days. The median gap between filing days is 2 days. The latest filing is dated 2026-11-04, four days before the record date, and is of type directors_dealings. On the exchange, the median cadence gap is 6.0 days, the median filings figure is 52, and the median latency is 5.0 days across 4359 issuers. In the sector, the median cadence gap is 5.5 days, the median filings figure is 65.5, and the median latency is 4.0 days across 176 issuers. By type, the window holds 3 agm_egm, 5 corporate_news, 2 director_change, 72 directors_dealings, 4 prospectus, 75 regulatory_filing and 8 results filings. ## Auditor The auditor is not on the record, because the latest annual report cover carries no dei:AuditorName tag. The auditor location is not on the record. The record holds no auditor changes. ## Events and halts The record holds no listing, delisting or name change lines. The domicile change is not on the record, because EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, because the exchanges' tier transfers are not EDGAR filings. The halt flag is listed, not halted. ## Orderability The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04. ## Coverage No research houses were found on the issuer's investor-relations pages read. The count is 0. ## Open research No openly published research notes were found. The count is 0. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The issuer's years sealed are 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12. The market's vintage is sealed. ## Sources 7 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin) - https://data.sec.gov/submissions/CIK0001601830.json (identity.jurisdiction) - https://mcp.us-cm-kg.ai/events/NASDAQ/RXRX (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.us-cm-kg.ai/record/NASDAQ/RXRX (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/RXRX · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp